Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
Fusaroli, Michele, Polizzi, Stefano, Menestrina, Luca, Giunchi, Valentina, Pellegrini, Luca, Raschi, Emanuel, Weintraub, Daniel, Recanatini, Maurizio, Castellani, Gastone, De Ponti, Fabrizio and Poluzzi, Elisabetta
(2024)
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.
Drug Safety.
ISSN 1179-1942
Impulsivity induced by dopaminergic agents, like pramipexole and aripiprazole, can lead to behavioral addictions that impact on social functioning and quality of life of patients and families (e.g., resulting in unemployment, marital problems, anxiety). These secondary effects, interconnected in networks of signs and symptoms, are usually overlooked by clinical trials, not reported in package inserts, and neglected in clinical practice.
Item Type | Article |
---|---|
Additional information | © 2024 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC), https://creativecommons.org/licenses/by-nc/4.0/ |
Date Deposited | 15 May 2025 15:41 |
Last Modified | 31 May 2025 00:45 |